Welcome back to the Biotech Stock Mailbag. This week’s stocks: Intercept Pharmaceuticals (ICPT - Get Report) , Acadia Pharmaceuticals (ACAD - Get Report) (an acquisition target?), Keryx Biopharmaceuticals (KERX - Get Report) and Galena Biopharma (GALE) . Read on, please!
Helen W. writes, “Thank you for the live blog covering Acadia Pharmaceuticals. I hope you do the same for Intercept Pharmaceuticals next week. Do you also expect this [Intercept] panel to end with a positive vote?”
I will live blog the Intercept FDA advisory panel on Thursday, April 7, probably the afternoon session, like I did with Acadia on Tuesday.
